Roman Nawroth

4PUBLICATIONS
21CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 09, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.

Sebastian Johannes Schober, Caroline Schoening, Jennifer Eck

|Aug 10, 2022
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.

Jana Koch, Sebastian J Schober, Sruthi V Hindupur

|Jan 23, 2018
Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.

Anuja Sathe, Géraldine Chalaud, Immanuel Oppolzer

Pageof 1